Related Experiment Video
Updated: Sep 6, 2025
Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
Published on: June 17, 2022
Application and Design of Switches Used in CAR
Paweł Głowacki1, Piotr Rieske1,2
1Department of Tumor Biology, Chair of Medical Biology, Medical University of Lodz, Zeligowskiego 7/9 St., 90-752 Lodz, Poland.
Abstract:
Among the many oncology therapies, few have generated as much excitement as CAR-T. The success of CAR therapy would not have been possible without the many discoveries that preceded it, most notably, the Nobel Prize-winning breakthroughs in cellular immunity. However, despite the fact that CAR-T already offers not only hope for development, but measurable results in the treatment of hematological malignancies, CAR-T still cannot be safely applied to solid tumors. The reason for this is, among other things, the lack of tumor-specific antigens which, in therapy, threatens to cause a lethal attack of lymphocytes on healthy cells. In the case of hematological malignancies, dangerous complications such as cytokine release syndrome may occur. Scientists have responded to these clinical challenges with molecular switches. They make it possible to remotely control CAR lymphocytes after they have already been administered to the patient. Moreover, they offer many additional capabilities. For example, they can be used to switch CAR antigenic specificity, create logic gates, or produce local activation under heat or light. They can also be coupled with costimulatory domains, used for the regulation of interleukin secretion, or to prevent CAR exhaustion. More complex modifications will probably require a combination of reprogramming (iPSc) technology with genome editing (CRISPR) and allogenic (off the shelf) CAR-T production.
Insights
Chimeric antigen receptor T-cell (CAR-T) therapy shows promise for blood cancers but faces challenges with solid tumors. Molecular switches offer remote control and enhanced capabilities for CAR-T cells, improving safety and efficacy.
Area of Science:
- Immunotherapy
- Oncology
- Cellular Engineering
Background:
- Chimeric antigen receptor T-cell (CAR-T) therapy has shown significant success in treating hematological malignancies.
- Current CAR-T therapy faces limitations in treating solid tumors due to the lack of tumor-specific antigens and potential off-target toxicity.
- Complications like cytokine release syndrome can occur with CAR-T therapy in blood cancers.
Purpose of the Study:
- To explore advanced strategies for enhancing CAR-T therapy safety and efficacy.
- To introduce molecular switches as a method for precise control over CAR-T cell activity.
- To address the challenges associated with applying CAR-T therapy to solid tumors.
Main Methods:
- Development and implementation of molecular switches to remotely control CAR-T lymphocytes post-administration.
- Engineering CAR-T cells with enhanced functionalities such as adjustable antigenic specificity and logic-gated activation.
- Investigating the combination of induced pluripotent stem cell (iPSC) technology, CRISPR genome editing, and allogeneic CAR-T production for complex modifications.
Main Results:
- Molecular switches enable remote control of CAR-T cells, offering enhanced safety and therapeutic potential.
- These switches provide additional capabilities including antigen specificity switching, logic gate formation, and localized activation (heat/light).
- Further modifications can be achieved through the integration of iPSC, CRISPR, and allogeneic CAR-T approaches.
Conclusions:
- Molecular switches represent a significant advancement in overcoming CAR-T therapy's limitations, particularly for solid tumors.
- These engineered controls enhance safety by allowing remote regulation and reduce off-target effects.
- Future directions involve combining advanced technologies for more sophisticated and broadly applicable CAR-T therapies.
More Related Videos
Related Concept Videos
01:14Design Example: Automobile Ignition System
One can generate a large voltage using a car battery of 12 volts with the help of inductors. Inductors are known for opposing...
01:26PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
01:22Switching of BJT
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
01:25Control Systems: Applications
In modern vehicles, control systems manage various functions to enhance performance and safety. The steering wheel and accelerator are primary inputs in a car's control system. The...
01:23Design Example
01:23Circuit Breaker and Fuse Selection
In high-voltage systems,...